Streptacare Suspension for Injection

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Dihydrostreptomycin Sulphate, Procaine Benzylpenicillin

Available from:

Norbrook Laboratories Limited

ATC code:

QJ01RA01

INN (International Name):

Dihydrostreptomycin Sulphate, Procaine Benzylpenicillin

Pharmaceutical form:

Suspension for injection

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cattle, Horses, Pigs, Sheep

Therapeutic area:

Antimicrobial

Authorization status:

Expired

Authorization date:

1998-04-30

Summary of Product characteristics

Revised: April 2022
AN: 01906/2021
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Streptacare Suspension for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Substance:
Each ml contains:
Procaine penicillin
200 mg
Dihydrostreptomycin Sulfate
250 mg
EXCIPIENTS:
Hydroxybenzoate Esters (Nipasept sodium)
1.5 mg
[as antimicrobial preservatives
methyl parahydroxybenzoate
1.07 mg*
ethyl parahydroxybenzoate
0.25 mg*
propyl parahydroxybenzoate
0.145 mg*
(* as approximate amounts)]
Sodium formaldehyde sulphoxylate dihydrate as antioxidant 1.25 mg.
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Suspension for injection.
A white to off-white suspension.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
Horses
Sheep
Pigs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of systemic infections in cattle, horses, sheep and
pigs
caused
by
or
associated
with
organisms
sensitive
to
penicillin
and/or
streptomycin including:
Revised: April 2022
AN: 01906/2021
Page 2 of 6
_Arcanobacterium pyogenes_
_Erysipelothrix rhusiopathiae_
_Klebsiella pneumoniae_
_Listeria _spp
_Mannheimia haemolytica_
_Pasteurella multocida_
_Staphylococcus _spp (non-penicillinase producing)
_Streptococcus _spp
_Salmonella _spp
And for the control of secondary bacterial infection with sensitive
organisms in
diseases primarily associated with viral infection.
4.3
CONTRAINDICATIONS
Contraindicated in known cases of hypersensitivity to penicillins.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Use with care in animals known to have kidney disease or defective
renal
function.
Do not exceed the recommended dosage or duration of treatment.
4.5
SPECIAL PRECAUTIONS FOR USE
i)
Special precautions for use in animals
Wherever possible, use of Streptacare should be based on
susceptibility
testing.
Care
should
be
taken
not
to
exceed
the
recommended
dosage.
Aminoglycosides have a narrower margin of safety than beta lactam
antibiotics.
ii)
Special
precautions
to
be
taken
by
t